Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

9.730 +0.210 (+2.21%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Why Gene-Editing Giants Crispr And Intellia Just Surged
The companies are working on one-and-done treatments for diseases tied to genetic problems. 
Via Investor's Business Daily
Topics Death
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies
The company remains confident in its other gene-editing product, which would treat a swelling disorder. 
Via Investor's Business Daily
Topics Death
2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street
Wall Street may be overestimating these companies' potential. 
Via The Motley Fool
Discover the top movers in Friday's pre-market session.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials
Intellia stock plunges after FDA places clinical hold on its Phase 3 trials for lead candidate nex-z, overshadowing Q3 earnings. 
Via Chartmill
What's going on in today's after hours session
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as... 
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130%
Maybe Cathie Wood and Wall Street are being too optimistic. 
Via The Motley Fool
Topics Death
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Meta, eBay, Microsoft And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
What's going on in today's after hours session
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Intellia Therapeutics Stock Is Diving Again: Here's Why
Intellia Therapeutics shares are tumbling in after-hours trading on Wednesday. Here's what you need to know. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
This Boot Barn Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
 
Via Benzinga
Which stocks are moving on Monday?
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today
Qualcomm shares were up more than 11% in Monday’s midday session after the company unveiled two AI accelerator chips. 
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Gold Falls 3%; Carter's Shares Gain After Q3 Earnings
 
Via Benzinga
Which stocks are gapping on Monday?
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event. 
Via Benzinga
Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results
 
Via Benzinga
These stocks are moving in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Why Did NTLA Stock Tumble 43% Pre-Market Today?
Intellia said that it has temporarily paused patient dosing and screening for two of its late-stage trials for Nex-z. 
Via Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.